Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines
- 6 October 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (43), 7456-7462
- https://doi.org/10.1016/j.vaccine.2011.07.054
Abstract
No abstract availableKeywords
Funding Information
- NIH (1 U01 AI070443-01)
This publication has 23 references indexed in Scilit:
- Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous systemEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile VirusJournal of Virology, 2005
- Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine DevelopmentJournal of Virology, 2003
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus VaccineJournal of Virology, 2000
- Stability of 17D Yellow Fever Virus Vaccine Using Different StabilizersBiologicals, 1998
- Design and Development of Adjuvant-Active Nonionic Block CopolymersJournal of Pharmaceutical Sciences, 1998
- Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteersVaccine, 1996
- Dengue Virus-Specific Memory T Cell Responses in Human Volunteers Receiving a Live Attenuated Dengue Virus Type 2 Candidate VaccineThe Journal of Infectious Diseases, 1994
- The Development of a Stable Smallpox VaccineEpidemiology and Infection, 1955